Drug Related Problems in Patients with Chronic Diseases during Home Visits by Pharmacists in the Family Care Team of Promkiri District Health Network
Article Sidebar
Main Article Content
Abstract
Objective: To identify drug related problems (DRPs) in patients with chronic diseases during home visits by pharmacists in the family care team of Promkiri district health network. Method: Subjects were patients with chronic diseases selected by Promkiri hospital in the fiscal year 2015 to be visited at homes by multidisciplinary teams. Home visits were based on holistic care and INHOMESSS approach (immobility, nutrition, home environment, other people, medication, examination, safety, spiritual health และ service) covering physical, psychological, social and environmental care. The pharmacist identified DRPs by interviewing patients and their care takers, examining patients’ history in database of the Hospital, checking medication use of patients, observing drug taking and storage, performing basic physical examination to evaluate outcomes of drug treatment, identifying adverse drug reactions, testing suspected herbal or health products for steroids contamination using test kit. Pharmacist recorded identified DRPs and problem solving methods. Classification of DRPs was based on the definition of Hepler and Strand. Results: The majority of 229 patients with home were female (76.53%) with an average age of 72.58+10.21 years. Three most common chronic diseases were diabetes (42.79%) hypertension (39.74%) and cardiovascular diseases (38.43%). Patient were visited at home on average 2.05+0.62times (range 1-3) within 12 months. The pharmacist identified DRPs in 74 patients. Four most prevalent DRPs were not receiving necessary drugs (31.08% of identified DRPs), receiving sub-therapeutic dose (28.38% of identified DRPs), receiving overdosed medications (18.92% of identified DRPs) and receiving medications without indications (10.81% of identified DRPs). Identified DRPs in all patients were resolved. Conclusion: Pharmacists played an important role in family care team as a case manager in resolving DRPs in patients with chronic diseases, and strengthening patient care team leading to an improved outcome.
Article Details
ผลการวิจัยและความคิดเห็นที่ปรากฏในบทความถือเป็นความคิดเห็นและอยู่ในความรับผิดชอบของผู้นิพนธ์ มิใช่ความเห็นหรือความรับผิดชอบของกองบรรณาธิการ หรือคณะเภสัชศาสตร์ มหาวิทยาลัยสงขลานครินทร์ ทั้งนี้ไม่รวมความผิดพลาดอันเกิดจากการพิมพ์ บทความที่ได้รับการเผยแพร่โดยวารสารเภสัชกรรมไทยถือเป็นสิทธิ์ของวารสารฯ
References
2. Pothisat S, Couny N, Udomchairat R, Prechachaiwit P, Konlaeard S, Miratanaprat S, at al. Literature review: the current situation and care model of non-communicable disease. Nonthaburi: Institute of Medical Research and Technology Assessment, 2014.
3. Suwanwela NC. Stroke epidemiology in Thailand. J Stroke 2014; 16: 1-7.
4. Ministry of Public Health. Development plan for public health service system (service plan). Nonthaburi: Ministry of Public Health; 2012.
5. Leesathapornwongsa P. Action plan of role of primary care pharmacy in universal coverage system [online]. 2011. [cited Jan 5, 2016]. Available from: thaihp.org/index2.php?option=show file&tbl=home&id=697.
6. Primary Care Pharmacy Working Group. Handbook for pharmacists working in primary care units. Bangkok: Office of Health Consumer Protection Plan, 2011.
7. Department of Pharmacy and Health Consumer Protection, Kranuan Crown Prince Hospital. Report of drug related problems in patients with chronic diseases. Khonkaen: Kranuan Crown Prince Hospital; 2010.
8. Peterson GM, Fitzmaurice KD, Naunton M, Vial JH, Stewart k. Impact of pharmacist-conducted home visits on the outcomes of lipid-lowering drug therapy. J Clin Pharm Ther 2005; 29: 23-30.
9. Nisittra P. Effects of discharge counseling and home-based interventions provided by pharmacist among elderly patients [dissertation]. Khon kaen: Khon kaen University; 2007.
10. Thaungsuwan W, Jedsadayanmata A. Effect of pharmacist participation in multidisciplinary team for home visit on blood pressure and drug adherence of stroke
patients. Thai Journal of Pharmacy Practice 2016; 8: 48-57.
11. Maneerat M, Waleekhachonloet O, Phumart P, Sangasri P. Effect of home health care by pharmacy students on knowledge, compliance and wasted drug problems in households. Thai Journal of Pharmacy Practice 2010; 2: 24-34.
12. Tunpichart S, Sakulbumrungsil R, Somrongthong R, Hongsamoot D. Chronic care model for diabeticst by pharmacist home health in Bankok metropolitan: a community based study. Int J Med Med Sci 2012; 4: 90-6.
13. Ningsanon T. Monthakarnkul P, Wanakmanee U, Suansanea T, Chatuporn T. Textbook of family pharmacist. Bangkok: The Association of Hospital Pharmacy (Thailand); 2014.
14. Unwin BK, Jerant AF. The home visit. Am Fam Physician 1999; 1481-8.
15. Hepler CD. Strand LM. Opportunities and responsibilities in pharmaceutical care. Am J Hosp Pharm 1990; 47:533-43.
16. Rachaniyom S, Saramunee K. Family pharmacist ’s management of drug related problem for chronic diseases at patient’s in home, Kranuan district health network. Thai Journal of Pharmacy Practice 2016; 8: 169-81.
17. Chayanattapong P. Stories from the communities (hope of those with one foot in the grave). Clinic 2015; 31: 761-5.
18. Chayanattapong P. Stories from the communities (may not be a strong enough drug). Clinic 2015; 31: 1111-4.
19. Chayanattapong P. Stories from the communities (three lives-relationship in the circle of sickness). Clinic 2015; 31: 861-4.
20. Chayanattapong P. Stories from the communities (Pla’s end of life). Clinic 2015; 31: 1339-43.
21. Ensing HT, Koste ES, Stuijt CCM, van Dooren AA, Bouvy ML. Bridging the gap between hospital and primary care: the pharmacist home visit. Int J Clin Pharm 2015;
37: 430-4.
22. Weerawattanachai C. Factors affecting drug related problems in diabetic inpatients at Rajavithi hospital [master thesis]. Bangkok: Chulalongkorn University, 2002.
23. Hajjar ER, Cafiero AC, Hanlon JT. Polypharmacy in elderly patients. Am J Geriatr Pharmacother 2007; 5: 345-51.
24. Fiβ T, Meinke–Franze C, van den Berg N, Hoffmann W. Effects of a three party healthcare network on the incidence levels of drug related problems. Int J Clin Pharm 2013; 35:763-71.
